Organo-Metalloid Compounds

Organo-metalloid compounds possess direct bonds between carbon atoms and metalloid atoms. Organo-metalloid compounds are available in a range of chemical compositions, quantities, purities, and reagent grades.

Search Within Results

3,976 – 3,990 of 4,237 results

3,976

eMolecules 88189-03-1 | Bismuth(III) trifluoromethanesulfonate | Ambeed | MFCD02093669 | 656.170 | C3BiF9O9S3 | 98.000 | [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F | 250mg | 534082828

Bismuth(III) trifluoromethanesulfonate | Ambeed | 88189-03-1 | MFCD02093669 | 656.170 | C3BiF9O9S3 | 98.000 | [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F | 250mg | 534082828

Pricing & Availability

3,977

Medchemexpress LLC Methyltetrazine-amido-PEG5-alkyne | 2322322-23-4 | C24H33N5O6 | 50 MG

Methyltetrazine-amido-PEG5-alkyne is a PEG-based PROTAC linker used in the synthesis of PROTACs. PROTACs consist of two different ligands connected by a linker; one ligand targets an E3 ubiquitin ligase, and the other targets a protein, utilizing the intracellular ubiquitin-proteasome system to selectively degrade target proteins. It is for research use only and not sold to patients.

PEG-based PROTAC linker
Used in PROTAC synthesis
Targets E3 ubiquitin ligase and a protein
Utilizes ubiquitin-proteasome system for selective protein degradation
Compatible with click chemistry (alkynes, tetrazine)
Applicable in cancer and targeted cancer therapy research

Pricing & Availability

3,978

eMolecules 121936-51-4 | 4-(TERT-BUTYLDIMETHYLSILYLOXY) CYCLOHEXANAMINE | MFCD18206131 | 1g

Pharmablock | 7-chloro-1H-16-naphthyridin-2-one | 25mg | 714320331 | PB96711 | 1345091-18-0 | MFCD22548048 | 180.590 | C8H5ClN2O

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>

Pricing & Availability

3,979

Apexbio Technology LLC Epidermal growth factor receptor (994-1002) acetyl/amide 1mg

Epidermal growth factor receptor 994-1002 acetyl amide is a peptide fragment derived from the epidermal growth factor receptor (EGFR) acetylated and amidated at its termini It is designed to serve as a tool for investigating receptor-ligand interactions and receptor activation mechanisms associated with EGFR-mediated signaling pathways Epidermal growth factor receptor 994-1002 acetyl amide acts by enabling the study of EGFR activation particularly receptor dimerization and autophosphorylation processes Based on its biological characteristics this peptide has research potential in evaluating therapeutic strategies targeting EGFR-mediated oncogenesis including studies of proliferation differentiation migration and survival in malignancies such as glioblastoma and lung cancers